The last 10 years have seen the medicinal product industry go through some remarkable changes in practically every aspect of the business. The decade saw emergence of state-of-the-art technology for discovery of new products, development of lesser known regulatory processes, global expansion of markets, increased regulatory oversight, and new financial models for funding development and increasing profitability. The next decade is expected to be the decade for emergence of personalized medicine, shifting of focus of healthcare from treatment to prevention, biotech products overtaking chemical drugs in number of products, new business models. This year in our seminar series we will discuss the various developments of the past decade and how they could yield more productivity, higher quality of life, better products, and sustained profitability of the medicinal product development business.
The list of topics and tentative dates are:
January 26th
Biosimilars: Past, Present and Future
February 23rd
Statistical Issues with Developing Diagnostic Kits
March 30th
Healthcare Reforms and the Drug and Device Industry
April 27th
Patient Reported Outcomes in Clinical Trials: Better Endpoints,Bigger Issues
May 25th
Medical Device Regulation in India: What, When, Where and How of Getting Medical Devices to the Indian Marketplace
June 29th
India and China: Protecting Your Intellectual Property in Emerging Markets
July27th
Role of Strategic Planning in Drug Development: Increasing Success by Reducing Risk
August 31st
Botanical Drug Products: Addressing CMC Issues for Complex Products
September 28th
Government Grants: Money with Responsibility
October 26th
Doing Pharmaceutical Business in India
November 23rd
Therapies Based on Stem Cell: Hope and Hype
December 21st
Computational Modeling: In Silico Development of Drugs
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment